Bambusa Therapeutics’ IPO cash will support its pipeline of bispecific antibodies designed to offer advantages over currently ...

Democratic senators are investigating 10 insurers’ role in the Trump administration’s termination of 760,000 ACA enrollees’ ...

Topline Phase 3 results show Eli Lilly’s retatrutide beat Novo’s Ozempic on measures of blood sugar and weight loss in adults ...

The cost of waiting is not evenly distributed. Rural and critical access hospitals report under 50 percent adoption of even ...

At MedCity INVEST Digital Health, experts from Jona, Labcorp and Evvy discussed the drivers of consumer diagnostics.

Artiva Biotherapeutics attributed one of the fatalities to a drug used to prepare patients for cell therapy and not to the ...

Gilead Sciences is getting global rights to an experimental PepStar Therapeutics oral peptide designed to inhibit the IL-23 ...

Corxel Pharmaceuticals is catching up to others with oral GLP-1 obesity drugs, but the biotech claims its small molecule ...

Fractyl Health reported positive six-month trial results from an investigation of its Revita procedure last week, but shares ...

OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved ...

The GSK cancer immunotherapy Jemperli is now approved for treating advanced cases of rectal cancer harboring a particular ...

CareValidate expanded its HRT offering for telehealth companies, combining hormone therapy with provider access, pharmacy ...